Janumet Sales Data

Rank 62 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Janumet U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 62 (4) 4.65% -3.46%
Q3 2013 66 0.39% -6.08%
Q2 2013 66 (4) -1.98% -1.75%
Q1 2013 62 (7) 7.64% -0.61%
Q4 2012 69 (2) -2.34% -0.61%
Q3 2012 67 (3) 5.21% 0.92%
Q2 2012 70 (6) 2.07% 1.56%
Q1 2012 76 (7) 8.76% 5.97%
Q4 2011 83 (1) 3.95% 4.26%
Q3 2011 82 (4) -2.60% 1.52%
Q2 2011 78 (11) 8.93% 3.14%
Q1 2011 89

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
June 13, 2011FDA Approves Redesigned Labels for Some Merck Drugs
Hide
(web1)